Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 2555 Records) |
| Query Trace: Neoplasms and Braf[original query] |
|---|
| Treatment of stage IV colorectal cancer: A retrospective cohort study assessing whether failure of first?line treatment indicates failure of second?line treatment. Molecular and clinical oncology 2024 12 22 (1): 10. Hanna Peyerl, Gudrun Kreye, Martin Pecherstorfer, Josef Sing |
| Exploring somatic mutations in BRAF, KRAS, and NRAS as therapeutic targets in Saudi colorectal cancer patients through massive parallel sequencing and variant classification. Frontiers in pharmacology 2024 12 15 1498295. Thamer Abdulhamid Aljuhani, Noor Ahmad Shaik, Rahaf Talal Alqawas, Rana Y Bokhary, Mahmood Al-Mutadares, Hadiah Bassam Al Mahdi, Nuha Al-Rayes, Ashraf AbdulRahman El-Harouni, Ramu Elango, Babajan Banaganapalli, Zuhier Ahmad Aw |
| Association of pre-existing conditions with major driver mutations and PD-L1 expression in NSCLC. BMJ open respiratory research 2024 12 11 (1): . Peiling Chen, Xin Zheng, Caichen Li, Jianfu Li, Chen Yang, Yi Feng, Bo Cheng, Hengrui Liang, Zhichao Liu, Yi Zhao, Shan Xiong, Feng Li, Ran Zhong, Shuting Zhan, Huiting Wang, Yang Xiang, Wenhai Fu, Wenjun Ye, Bo'ao Jiang, Xianzhe Fan, Jun Liu, Jianxing He, Wenhua Lia |
| Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study. Molecular oncology 2024 12 . Susanne Klein-Scory, Alexander Baraniskin, Wolff Schmiegel, Thomas Mika, Roland Schroers, Swantje Held, Kathrin Heinrich, David Tougeron, Dominik P Modest, Ingo Schwaner, Jan Eucker, Rudolf Pihusch, Martina Stauch, Florian Kaiser, Christoph Kahl, Meinolf Karthaus, Christian Müller, Christof Burkart, Sebastian Stintzing, Volker Heinema |
| Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma. Molecular diagnosis & therapy 2024 12 . E Jutten, L C L T van Kempen, G F H Diercks, B L van Leeuwen, S Kruijff, K P Weve |
| Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108068. Mingying Wu, Na Zhou, Mei Guan, Yingyi Wang, Yuzhou Wa |
| Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer. Seminars in oncology 2024 12 . Laura Pala, Tommaso De Pas, Emilia Cocorocchio, Chiara Catania, Giovanni Ceresoli, Daniele Laszlo, Emma Zattarin, Giovanna Rossi, Fabio Confor |
| Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT Database. Current issues in molecular biology 2024 12 46 (12): 14476-14486. Shuhei Suzuki, Yosuke Saito, Koki Saito, Yuta Yamada, Koshi Takahashi, Ryosuke Kumanishi, Tadahisa Fukui, Takashi Yoshio |
| Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal Cancer. Current issues in molecular biology 2024 12 46 (12): 13617-13646. B?a?ej Ochman, Anna Kot, Sylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, Dominika Koszewska, Dorota Hudy, Monika Szrot, Jerzy Piecuch, Dariusz Waniczek, Zenon Czuba, El?bieta ?wi?tochows |
| Unraveling the Genetic Landscape of Langerhans Cell Histiocytosis in Korean Patients: Comprehensive Insights from Mutational Profiles and Clinical Correlations. Cancer research and treatment 2024 12 . Kyung-Nam Koh, Ha Ra Jun, Ji-Young Lee, Ji Young Kim, Su Hyun Yoon, Young Kwon Koh, Sung Han Kang, Hyery Kim, Ho Joon Im, Sung-Min Ch |
| COMPOSIT study: evaluating osimertinib combination with targeted therapies in EGFR-mutated non-small cell lung cancer. The oncologist 2024 12 . Camille Mehlman, Aurelie Swalduz, Isabelle Monnet, Clara Morin, Marie Wislez, Florian Guisier, Hubert Curcio, Pauline Du Rusquec, Alexis B Cortot, Valerie Gounant, Baptiste Abbar, Boris Duchemann, Etienne Giroux-Leprieur, Thomas Pierret, Fleur-Marie Quilot, Jacques Cadranel, Vincent Fall |
| Predictive role of [F]FDG PET-CT radiomic parameters for KRAS/BRAF/EGFR mutations in metastatic colorectal cancer patients. EJNMMI reports 2024 12 8 (1): 42. Magdi A Ali, Omar Shebl Zahra, Mohmed I Morsi, Mohamed M El Safwany, Shaymaa Essam El Fe |
| Clinical and genetic drivers of oligo-metastatic disease in colon cancer. Neoplasia (New York, N.Y.) 2024 12 60 101111. Alessandro Ottaiano, Mariachiara Santorsola, Roberto Sirica, Annabella Di Mauro, Antonella Di Carlo, Monica Ianniello, Francesco Sabbatino, Rosa Castiello, Francesca Del Peschio, Marco Cascella, Francesco Perri, Maurizio Capuozzo, Nicola Martucci, Edoardo Mercadante, Valentina Borzillo, Rossella Di Franco, Francesco Izzo, Vincenza Granata, Carmine Picone, Antonella Petrillo, Massimiliano Berretta, Salvatore Stilo, Luca Tarotto, Anna Chiara Carratù, Gerardo Ferrara, Madhura Tathode, Alessia Maria Cossu, Marco Bocchetti, Michele Caraglia, Guglielmo Nasti, Giovanni Savare |
| Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer. Translational cancer research 2024 12 13 (11): 6235-6245. Theodore Wang, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Matthew P De |
| Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay. BMC cancer 2024 12 24 (1): 1547. Mariana Bisarro Dos Reis, Wellington Dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarã |
| Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment. Cancers 2024 12 16 (23): . Vincenzo Formica, Antonio Di Grazia, Maria Vittoria Bonomo, Rachele Frascatani, Roberto Mancone, Giovanni Monteleo |
| High Prevalence of TBC1D12 5'UTR Mutations in Anaplastic Thyroid Cancer. Thyroid : official journal of the American Thyroid Association 2024 12 . Guanghui Hu, Junyu Xue, Ju Yu, Qianyi Dou, Ye Sang, Anjia Han, Weiming Lv, Jie Li, Rengyun L |
| PIK3CA Mutations and Co-Mutations in Operated Non-Small Cell Lung Carcinoma. Journal of clinical medicine 2024 12 13 (23): . Salih Cokpinar, Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Nesibe Kahraman-Cetin, Ibrahim Meteog |
| Prognostic impact of targetable driver alterations in resected early-stage lung cancer. Translational lung cancer research 2024 12 13 (11): 3096-3105. Angelika Terbuch, Selma Konjic, Verena Schlintl, Gudrun Absenger, Philipp J Jost, Jörg Lindenmann, Paul Swatek, Nikolaus John, Teresa John, Robert Wurm, Martin Zacharias, Florian Posch, Maximilian J Hochmair, Hannah Fabikan, Christoph Weinlinger, Oliver Illini, Lena Horvath, Gabriele Gamerith, Dominik Wolf, Florian Augustin, Luka Brc |
| Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1. Frontiers in oncology 2024 12 14 1473327. Zachary D Wallen, Mary K Nesline, Marni Tierno, Alison Roos, Erica Schnettler, Hatim Husain, Pratheesh Sathyan, Brian Caveney, Marcia Eisenberg, Eric A Severson, Shakti H Ramkisso |
| [Molecular pathology of gastrointestinal neoplasms]. Magyar onkologia 2024 12 68 (4): 325. Tamás Strausz, László Báthory-Fülöp, Eszter Papp, Erika Tó |
| Environmental Exposures and Canine Bladder Cancer: A Case Control Study Using Silicone Passive Samplers. Environmental science & technology 2025 1 . Catherine F Wise, Nicholas J Herkert, Kate Hoffman, Shelly Vaden, Matthew Breen, Heather M Staplet |
| Influence of Body Mass Index on the Clinicopathological Features of Papillary Thyroid Carcinoma in a Chinese Population. Metabolic syndrome and related disorders 2025 1 . Li Zhang, Shichen Xu, Xian Cheng, Yun Zhu, Gangming Cai, Jing Wu, Wenjing Gao, Jiandong Bao, Huixin |
| Colorectal Cancer and Its Microenvironment: A Brief Review. Medical journal of the Islamic Republic of Iran 2025 1 38 108. Nauryzbay M Imanbayev, Arip K Koyshybaev, Nurgul M Kereyeva, Marzhan A Aitmagambetova, Azamat B Zharylgap |
| Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF -mutated metastatic colorectal cancer treated with targeted therapy. Therapeutic advances in medical oncology 2025 1 17 17588359241299975. Guglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti, Lisa Salvatore, Filippo Pietrantonio, Sara Lonardi, Maria Bensi, Filippo Ghelardi, Maria Alessandra Calegari, Rossana Intini, Alessandro Minelli, Francesco Giulio Sullo, Chiara Boccaccio, Ada Taravella, Alberto Puccini, Daniele Lavacchi, Laura Noto, Massimiliano Salati, Mario Scartozzi, Chiara Cremoli |
| Colorectal Cancer: A Brief and Simplified Analysis of a Complex Disease. Medicina (Kaunas, Lithuania) 2025 1 60 (12): . Krasimir Petrov, Ivan Ivanov, Savelina Popovska, Tatyana Betova, Zornitsa Kamburo |
| Mutational and co-mutational landscape of early onset colorectal cancer. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2025 1 1-13. Jumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G White, John Paul Shen, Eduardo Vilar, Christine Parseghian, Arvind Dasari, Van Karlyle Morris, Ryan Huey, Michael J Overman, Robert Wolff, Kanwal P Raghav, Jason Willis, Kristin Alfaro, Andy Futreal, Y Nancy You, Scott Kope |
| Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications. Cancer science 2025 1 . Yuko Chikaishi, Hiroshi Matsuoka, Eiji Sugihara, Mayu Takeda, Makoto Sumitomo, Seiji Yamada, Gaku Inaguma, Yusuke Omura, Yeongcheol Cheong, Yosuke Kobayashi, Masaya Nakauchi, Junichiro Hiro, Koji Masumori, Koki Otsuka, Hiroshi Nishihara, Koichi Suda, Hideyuki Saya, Tetsuya Takimo |
| Differential Gene Set Enrichment of Epithelial-Mesenchymal Transition Pathway in BRAF vs. NRAS Mutated Metastatic Melanoma. Clinical and experimental dermatology 2025 1 . Victor J Raimundi-Santos, Tyrel R Port |
| Identification of clinicopathological-specific driver gene and genetic subtyping of colorectal cancer. Cancer science 2025 1 . Jianjiong Li, Chunnian Wang, Changshun Yang, Hua Bao, Ningyou Li, Xianqiang Huang, Wei Gong, Xinyue Hong, Jiani C Yin, Jiaohui Pang, Meifu Gan, Danping Yu |
- Page last reviewed:Feb 1, 2024
- Content source: